Last checked at 10 Jul 2017 12:00
10th July 2017
Kromek Group plc
("Kromek" or the "Group")
Publication of Annual Report
Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security screening and nuclear markets, announces that its annual report and accounts for the year ended 30 April 2017 has been made available on its website at www.kromek.com and will be posted to shareholders shortly.
Enquiries
Kromek Group plc | +44 (0)1740 626 060 |
Arnab Basu, CEO Derek Bulmer, CFO | |
Cenkos Securities plc | +44 (0)20 7397 8900 |
Bobbie Hilliam (NOMAD) Julian Morse (Sales) | |
Luther Pendragon | +44 (0)20 7618 9100 |
Harry Chathli, Claire Norbury, Alexis Gore | |
About Kromek Group plc
Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma photon imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.